The effect of desonide hydrogel on pruritis associated with atopic dermatitis.

Leon Kircik

Journal: Journal of drugs in dermatology : JDD 2015;13(6):725-8

PMID: 24918564

Abstract

Itch is a common and troubling symptom of atopic dermatitis. It is not mediated by histamine, and standard anti-itch therapies, therefore, have limited benefit for most AD patients. Instead, anti-inflammatory agents are used to reduce inflammation and therefore improve associated itch. Studies confirm that long-term use of corticosteroids can lead to a reduction in pruritus. A pilot study was designed to assess the effects of one week of twice-daily application of desonide hydrogel 0.05% for the treatment of atopic dermatitis. Active treatment was associated with significant improvements in IGA scores at day 3 and day 7 (mean score 0.55, 75.83% improvement from Baseline; P <.0001) and pruritus VAS scores at day 3 and day 7 (mean 6.35-point, 86.61% reduction in VAS scores; P <.0001). Treatment with the convenient, hydrating hydrogel formulation is effective and associated with an improvement in subjects' quality of life.

Link outs

Free resources

Medical:

https://medlineplus.gov/itching.html

Miscellaneous:

https://assays.cancer.gov/CPTAC-1178

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-ITCH-1

Subscription / membership required

Full Text Sources:

http://jddonline.com/articles/dermatology/S1545961...

MeSH Terms: Adolescent, Adult, Aged, Anti-Inflammatory Agents, Child, Dermatitis, Atopic, Desonide, Female, Humans, Hydrogel, Polyethylene Glycol Dimethacrylate, Male, Middle Aged, Pilot Projects, Pruritus, Quality of Life, Treatment Outcome, Young Adult